Company intelligence / Profile preview
Chengdu Brilliant Pharmaceutical
Chengdu, Sichuan, Chinabrilliantpharmaceutical.com ↗
- Ownership
- Private
- Employees
- ~5000
- Development stage
- Commercial
01
Overview
Chengdu Brilliant Pharmaceutical is a leading Chinese pharmaceutical company with a broad portfolio spanning innovative drugs and high-end generics. It has advanced R&D capabilities with over ten senior scientists leading teams focused on small molecules, biologics—including monoclonal antibodies—oligonucleotides, radiopharmaceuticals and Chinese patent medicines. The company’s semaglutide biosimilar for obesity is in Phase 3 trials; BPR‑101 for bacterial vaginosis is in Phase 2. The group also produces numerous commercialized generic products across major therapeutic areas.
- Therapeutic areas
- EndocrinologyWomen's Health
- Modalities
- Small moleculeBiologicOligonucleotideRecombinant proteinMonoclonal antibodyRadiopharmaceutical
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Not specifically listed; the company collaborates widely within China’s pharma sector.
Beyond the preview
Go deeper on Chengdu Brilliant Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chengdu Brilliant Pharmaceutical.